The Texas A&M Drug Discovery and Development Resource Center (3DRC) offers an integrated platform that accelerates therapeutic development by combining advanced capabilities in generative AI-driven ligand design, synthetic and medicinal chemistry, high-throughput screening, and data science.
Our Generative AI Platform leverages cutting-edge tools and models to design high-quality ligands, enhancing the efficiency of the discovery process. By utilizing machine learning methods, we can generate novel compounds with desired properties, streamlining the initial stages of drug development.
The Synthetic and Medicinal Chemistry Program provides state-of-the-art infrastructure for the synthesis and optimization of compounds. Our team of experts employs industry-standard instrumentation to create and refine molecules, ensuring they meet the necessary criteria for therapeutic efficacy and safety.
Our High-Throughput Screening Center supports a broad range of assay formats,and endpoints to enable rapid and comprehensive testing of compounds. Lower throughput high content assays for lead optimization and Toxicity profiling are also available.
Finally, the Screening Informatics and Data Science Program ensures robust data analysis and visualization throughout the drug discovery process. By integrating data science techniques, we can interpret complex datasets, facilitating informed decision-making and accelerating the development of novel therapeutics.